XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
BLUR Drops 32.1% on Frontend Deprecation News
BLUR dropped 32. 1% after the Blur NFT marketplace announced the deprecation of its frontend, triggering an immediate sell-off among holders of the platform’s n...
Solana ETF Launch Set for Hong Kong as U.S. Funds Lose $24.8M
Hong Kong is set to add a Solana ETF to its growing lineup of crypto investment products, extending the city’s push to position itself as a regulated hub for di...
Bitcoin Oct. 16 Options: $451M at $76K-$80K Strikes
Bitcoin puts expiring Oct. 16 concentrate roughly $451 million in notional value at the $76,000, $78,000 and $80,000 strikes, according to an Oct.
Eclair Merges Fixes for Lightning Fee-Loss Flaws
Eclair, the Lightning Network node implementation maintained by ACINQ, has merged fixes targeting fee-loss flaws that do not require stolen keys to exploit. The...
Moscow Exchange to Launch Bitcoin, Ethereum and USDT Trading
The announcement names three specific assets: Bitcoin (BTC), Ethereum (ETH) and Tether (USDT). No further operational details, such as trading pairs, fee struct...
Bitcoin Nears $85K as Ethereum Derivatives Flash Warnings
Bitcoin is pressing against the $85,000 resistance zone while Ethereum’s derivatives market, valued at $26. 5 billion, is showing early warning signals that tra...
